Macquarie Group LTD Vericel Corp Transaction History

Macquarie Group LTD

  • $87.4 Billion
  • Q1 2024

A detailed history of Macquarie Group LTD transactions in Vericel Corp stock. As of the latest transaction made, Macquarie Group LTD holds 1,082,696 shares of VCEL stock, worth $49.7 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,082,696
Previous 1,146,193 5.54%
Holding current value
$49.7 Million
Previous $40.8 Million 37.99%
% of portfolio
0.06%
Previous 0.05%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
SELL
$32.52 - $52.33 $2.06 Million - $3.32 Million
-63,497 Reduced 5.54%
1,082,696 $56.3 Million
Q4 2023

Feb 14, 2024
SELL
$30.85 - $37.09 $863,306 - $1.04 Million
-27,984 Reduced 2.38%
1,146,193 $40.8 Million
Q3 2023

Nov 14, 2023
SELL
$31.69 - $39.25 $1.1 Million - $1.36 Million
-34,565 Reduced 2.86%
1,174,177 $39.4 Million
Q2 2023

Aug 14, 2023
BUY
$29.0 - $38.37 $1.88 Million - $2.48 Million
64,666 Added 5.65%
1,208,742 $45.4 Million
Q1 2023

May 15, 2023
BUY
$23.85 - $31.34 $1.86 Million - $2.45 Million
78,158 Added 7.33%
1,144,076 $33.5 Million
Q4 2022

Feb 21, 2023
SELL
$17.65 - $27.37 $3.17 Million - $4.92 Million
-179,658 Reduced 14.42%
1,065,918 $28.1 Million
Q3 2022

Nov 14, 2022
SELL
$22.62 - $32.54 $6.73 Million - $9.68 Million
-297,614 Reduced 19.29%
1,245,576 $28.9 Million
Q2 2022

Aug 15, 2022
BUY
$22.88 - $39.45 $450,392 - $776,573
19,685 Added 1.29%
1,543,190 $38.9 Million
Q1 2022

May 16, 2022
SELL
$31.69 - $43.29 $12.6 Million - $17.3 Million
-398,775 Reduced 20.74%
1,523,505 $58.2 Million
Q4 2021

Feb 11, 2022
SELL
$35.2 - $52.6 $10.2 Million - $15.3 Million
-289,929 Reduced 13.11%
1,922,280 $75.5 Million
Q3 2021

Nov 12, 2021
BUY
$46.35 - $59.75 $11.1 Million - $14.3 Million
239,905 Added 12.16%
2,212,209 $108 Million
Q2 2021

Aug 13, 2021
BUY
$47.2 - $67.81 $93 Million - $134 Million
1,970,774 Added 128808.76%
1,972,304 $104 Million
Q1 2021

May 14, 2021
SELL
$30.93 - $59.48 $29,259 - $56,268
-946 Reduced 38.21%
1,530 $85,000
Q4 2020

Feb 16, 2021
BUY
$18.53 - $31.5 $16,677 - $28,350
900 Added 57.11%
2,476 $77,000
Q2 2020

Aug 11, 2020
BUY
$8.5 - $15.82 $13,396 - $24,932
1,576 New
1,576 $22,000
Q1 2019

May 15, 2019
SELL
$16.23 - $20.29 $11,361 - $14,203
-700 Closed
0 $0
Q4 2018

Feb 15, 2019
SELL
$10.77 - $18.44 $4,308 - $7,376
-400 Reduced 36.36%
700 $12,000
Q3 2018

Nov 15, 2018
SELL
$9.1 - $14.8 $45,500 - $74,000
-5,000 Reduced 81.97%
1,100 $16,000
Q2 2018

Aug 14, 2018
BUY
$9.6 - $14.6 $58,560 - $89,060
6,100 New
6,100 $59,000
Q1 2018

May 11, 2018
SELL
$5.7 - $12.3 $10,260 - $22,140
-1,800 Closed
0 $0
Q4 2017

Feb 15, 2018
BUY
$3.65 - $5.98 $6,570 - $10,764
1,800
1,800 $10,000

Others Institutions Holding VCEL

# of Institutions
263
Shares Held
48.9M
Call Options Held
150K
Put Options Held
128K
View Full List

About Vericel Corp

VCEL Quotes by TradingView
  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.16B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email